Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 3
2006 1
2008 1
2009 2
2010 4
2011 6
2012 5
2013 5
2014 6
2015 4
2017 6
2018 6
2019 13
2020 8
2021 8
2022 8
2023 15
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Attention for sex in COVID-19 trials: a review of regulatory dossiers.
de Vries ST, Starokozhko V, Schellens IMM, Wijnans L, Enzmann H, Cavaleri M, Mol PGM. de Vries ST, et al. Among authors: mol pgm. BMJ Glob Health. 2022 Mar;7(3):e008173. doi: 10.1136/bmjgh-2021-008173. BMJ Glob Health. 2022. PMID: 35304352 Free PMC article. Review.
Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap.
Starokozhko V, Kallio M, Kumlin Howell Å, Mäkinen Salmi A, Andrew-Nielsen G, Goldammer M, Burggraf M, Löbker W, Böhmer A, Agricola E, de Vries CS, Pasmooij AMG, Mol PGM; STARS consortium. Starokozhko V, et al. Among authors: mol pgm. Drug Discov Today. 2021 Feb;26(2):283-288. doi: 10.1016/j.drudis.2020.10.017. Epub 2020 Oct 27. Drug Discov Today. 2021. PMID: 33127567 Free article. Review.
Safety of continuing mineralocorticoid receptor antagonist treatment in patients with heart failure with reduced ejection fraction and severe kidney disease: Data from Swedish Heart Failure Registry.
Guidetti F, Lund LH, Benson L, Hage C, Musella F, Stolfo D, Mol PGM, Flammer AJ, Ruschitzka F, Dahlstrom U, Rosano GMC, Braun OÖ, Savarese G. Guidetti F, et al. Among authors: mol pgm. Eur J Heart Fail. 2023 Dec;25(12):2164-2173. doi: 10.1002/ejhf.3049. Epub 2023 Oct 18. Eur J Heart Fail. 2023. PMID: 37795642
[Interaction between clopidogrel and proton pump inhibitors].
Harmsze AM, de Boer A, Boot H, Deneer VH, Heringa M, Mol PG, Schalekamp T, Verduijn MM, Verheugt FW, le Comte M. Harmsze AM, et al. Among authors: mol pg. Ned Tijdschr Geneeskd. 2011;155(28):A2442. Ned Tijdschr Geneeskd. 2011. PMID: 21771377 Review. Dutch.
Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance.
Bahri P, Bowring G, Edwards BD, Anton C, Aronson JK, Caro-Rojas A, Hugman BPJ, Mol PG, Trifirò G, Ilic K, Daghfous R, Fermont I, Furlan G, Gaissmaier W, Geer MI, Hartigan-Go KY, Houÿez F, Neth H, Norgela G, Oppamayun Y, Raynor DKT, Bouhlel M, Santoro F, Sultana J. Bahri P, et al. Among authors: mol pg. Drug Saf. 2023 Jun;46(6):517-532. doi: 10.1007/s40264-023-01285-5. Epub 2023 May 23. Drug Saf. 2023. PMID: 37219785 Free PMC article. Review. No abstract available.
Registries supporting new drug applications.
Jonker CJ, van den Berg HM, Kwa MSG, Hoes AW, Mol PGM. Jonker CJ, et al. Among authors: mol pgm. Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1451-1457. doi: 10.1002/pds.4332. Epub 2017 Oct 6. Pharmacoepidemiol Drug Saf. 2017. PMID: 28983992 Free PMC article.
97 results